Cargando…
Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion
We investigated the effect of trifluoperazine (TFP), a calmodulin antagonist, on the fusion of chick skeletal myoblasts in culture. TFP was found to inhibit myoblast fusion. This effect occurs at concentrations that have been reported to inhibit Ca2+-calmodulin in vitro, and is reversed upon removal...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2112681/ https://www.ncbi.nlm.nih.gov/pubmed/6415064 |
Ejemplares similares
-
The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis
por: Mao, Yizhi, et al.
Publicado: (2022) -
Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
por: Kamath, N., et al.
Publicado: (1993) -
Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
por: Mircheva, J., et al.
Publicado: (1986) -
Inhibition of dengue virus infection by trifluoperazine
por: Piccini, Luana E., et al.
Publicado: (2022) -
Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
por: Ganapathi, R., et al.
Publicado: (1988)